AHA 2024 and Acoramidis: Impact on the Future of ATTR-CM Patient Care
AHA 2024 and Acoramidis: Impact on the Future of ATTR-CM Patient Care
The AMA MAP™ Hypertension Program in Action: Insights from Grace Health
The AMA MAP™ Hypertension Program in Action: Insights from Grace Health
Examining CVD in Lupus: Insights from a Diverse Population-Based Registry
Examining CVD in Lupus: Insights from a Diverse Population-Based Registry
Bempedoic acid reduces adverse limb events in patients with PAD
Bempedoic acid reduces adverse limb events in patients with PAD
No benefit of routine spironolactone post-MI
No benefit of routine spironolactone post-MI
From Symptoms to Diagnosis: Navigating ATTR Amyloidosis in Clinical Practice
From Symptoms to Diagnosis: Navigating ATTR Amyloidosis in Clinical Practice
Uncovering Unmet Needs in ATTR Amyloidosis
Uncovering Unmet Needs in ATTR Amyloidosis
Unraveling Hereditary ATTR Amyloidosis: Key Variants and Clinical Insights
Unraveling Hereditary ATTR Amyloidosis: Key Variants and Clinical Insights
Improving Outcomes in hATTR-PN: The Role of Vigilant Symptom Assessment
Improving Outcomes in hATTR-PN: The Role of Vigilant Symptom Assessment
Clinical Perspectives on Prioritizing LDL-C Management After a Recent Coronary Event
Clinical Perspectives on Prioritizing LDL-C Management After a Recent Coronary Event
medicaldialogues.in
eurekalert.org
medicaldialogues.in
medicalxpress.com
medicalxpress.com
medicalxpress.com
